ACETのニュース
Adicet Bio Inc. (NASDAQ:ACET) Stock Has Fallen -20.13% YTD, What Do Analysts Anticipate Next? 2023/03/11 13:00:00 Marketing Sentinel
In last trading session, Adicet Bio Inc. (NASDAQ:ACET) saw 0.65 million shares changing hands with its beta currently measuring 2.27. Company’s recent per share price level of $7.14 trading at -$0.3 or -4.03% at ring of the bell on the day assigns it a market valuation of $296.88M. That closing price of ACET’s stock is … Adicet Bio Inc. (NASDAQ:ACET) Stock Has Fallen -20.13% YTD, What Do Analysts Anticipate Next? Read More »
Adicet Bio: Searching For Upside In Cell Therapeutics (NASDAQ:ACET) 2023/02/07 19:24:45 Seeking Alpha
All eyes are on Adicet Bio as a pivotal study is launched into its cell therapeutics. Read more to see why Adicet stands out from the CAR-T crowd.
Ontario Securities Commission Lawsuit Against Former Canntrust Executives Lands On Its Face 2022/12/20 19:53:12 Benzinga
The Ontario Securities Commission asked for a leave to withdraw the charges against former CannTrust Holdings Inc. (OTCEM:CNTTQ) CEO Peter Aceto , former chairman Eric Paul and former vice-chairman Mark Litwin on December 14 th , reported Global News. The three former executives were charged with fraud and authorizing, permitting or acquiescing in the commission of an offense. Litwin and Paul were also facing insider trading charges. Litwin and Aceto were charged with making a false prospectus and false preliminary prospectus. According to Graham Lee , a former director of quality and compliance, cultivation in unlicensed spaces was discussed “very openly” at the company. The OSC’s case fell apart when Litwin’s … Full story available on Benzinga.com
Sector Declining Stock: Adicet Bio, Inc. (NASDAQ:ACET -39.54%), Unum Group (NYSE:UNM -0.75%) 2022/12/13 00:05:15 Stock Equity
Adicet Bio, Inc. (NASDAQ:ACET) with the stream of -39.54% also noticed, India Unum Group (NYSE:UNM) encountered a rapid change of -0.75% in the last hour of Tuesday’s trading session. Adicet … The post Sector Declining Stock: Adicet Bio, Inc. (NASDAQ:ACET -39.54%), Unum Group (NYSE:UNM -0.75%) appeared first on Stocks Equity .
Adicet Bio Stock Craters on Phase 1 Clinical Data 2022/12/12 19:20:01 TipRanks
Midday trading for Adicet Bio on Monday (NASDAQ:ACET) turned sharply down. The company has lost over 36.7% so far in trading, and it all seems to be thanks to the results from ongoing Phase 1 clinical studies. The studies in question focused on a drug known as ADI-001, a treatment for B-Cell Non-Hodgkin''s Lymphoma. It''s specifically for patients who either have the disease in an aggressive form that is either “relapsed or refractory.” The news proved welcome on some fronts, including “high overall response rates” and “…a manageable side effect profile”. However, the news about the majority of patients relapsing within six months of use proved a problem.
Adicet Bio: Searching For Upside In Cell Therapeutics (NASDAQ:ACET) 2023/02/07 19:24:45 Seeking Alpha
All eyes are on Adicet Bio as a pivotal study is launched into its cell therapeutics. Read more to see why Adicet stands out from the CAR-T crowd.
Ontario Securities Commission Lawsuit Against Former Canntrust Executives Lands On Its Face 2022/12/20 19:53:12 Benzinga
The Ontario Securities Commission asked for a leave to withdraw the charges against former CannTrust Holdings Inc. (OTCEM:CNTTQ) CEO Peter Aceto , former chairman Eric Paul and former vice-chairman Mark Litwin on December 14 th , reported Global News. The three former executives were charged with fraud and authorizing, permitting or acquiescing in the commission of an offense. Litwin and Paul were also facing insider trading charges. Litwin and Aceto were charged with making a false prospectus and false preliminary prospectus. According to Graham Lee , a former director of quality and compliance, cultivation in unlicensed spaces was discussed “very openly” at the company. The OSC’s case fell apart when Litwin’s … Full story available on Benzinga.com
Sector Declining Stock: Adicet Bio, Inc. (NASDAQ:ACET -39.54%), Unum Group (NYSE:UNM -0.75%) 2022/12/13 00:05:15 Stock Equity
Adicet Bio, Inc. (NASDAQ:ACET) with the stream of -39.54% also noticed, India Unum Group (NYSE:UNM) encountered a rapid change of -0.75% in the last hour of Tuesday’s trading session. Adicet … The post Sector Declining Stock: Adicet Bio, Inc. (NASDAQ:ACET -39.54%), Unum Group (NYSE:UNM -0.75%) appeared first on Stocks Equity .
Adicet Bio Stock Craters on Phase 1 Clinical Data 2022/12/12 19:20:01 TipRanks
Midday trading for Adicet Bio on Monday (NASDAQ:ACET) turned sharply down. The company has lost over 36.7% so far in trading, and it all seems to be thanks to the results from ongoing Phase 1 clinical studies. The studies in question focused on a drug known as ADI-001, a treatment for B-Cell Non-Hodgkin''s Lymphoma. It''s specifically for patients who either have the disease in an aggressive form that is either “relapsed or refractory.” The news proved welcome on some fronts, including “high overall response rates” and “…a manageable side effect profile”. However, the news about the majority of patients relapsing within six months of use proved a problem.
ACET stock plunges after updating Phase 1 data for blood cancer therapy (NASDAQ:ACET) 2022/12/12 16:02:22 Seeking Alpha
Adicet Bio (ACET) dropped ~38% on Monday after the company updated data from an ongoing Phase 1 trial for its experimental CAR T cell ADI-001 in blood cancer. Read full story here.
ACET stock drops ahead of updated Phase 1 data for blood cancer therapy (NASDAQ:ACET) 2022/12/09 19:47:50 Seeking Alpha
Cancer-focused biotech Adicet Bio (ACET) fell ~12% on Friday as the company prepares for an updated data readout from its Phase 1 study for CAR T cell therapy ADI-001 in relapsed…
Adicet Bio Inc. (ACET) is an excellent investment, but the stock is overvalued/undervalued right now 2022/11/15 19:40:00 US Post News
In Monday’s session, Adicet Bio Inc. (NASDAQ:ACET) marked $20.74 per share, down from $21.27 in the previous session. While Adicet Bio Inc. has underperformed by -2.49%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, ACET rose by 112.72%, with highs and lows ranging from $21.87 to […]
Adicet Bio Inc. (NASDAQ:ACET) Could Really Rise To $34.00 In 12 Months, According To Analysts. 2022/10/15 15:30:00 Marketing Sentinel
In last trading session, Adicet Bio Inc. (NASDAQ:ACET) saw 0.35 million shares changing hands with its beta currently measuring 2.15. Company’s recent per share price level of $16.61 trading at -$0.19 or -1.13% at ring of the bell on the day assigns it a market valuation of $746.29M. That closing price of ACET’s stock is … Adicet Bio Inc. (NASDAQ:ACET) Could Really Rise To $34.00 In 12 Months, According To Analysts. Read More »
Adicet Bio Inc. (NASDAQ:ACET) Currently -52.3% Below Its 52-Week High, But There May Be A Surprise Downside 2022/09/24 11:30:00 Marketing Sentinel
In last trading session, Adicet Bio Inc. (NASDAQ:ACET) saw 0.72 million shares changing hands with its beta currently measuring 2.26. Company’s recent per share price level of $13.90 trading at $0.24 or 1.76% at ring of the bell on the day assigns it a market valuation of $644.26M. That closing price of ACET’s stock is … Adicet Bio Inc. (NASDAQ:ACET) Currently -52.3% Below Its 52-Week High, But There May Be A Surprise Downside Read More »
Following Its 52-Week Low, Adicet Bio Inc. (NASDAQ: ACET)’S Share Price Rose 54.15% And Its YTD Numbers Fell -22.07% 2022/06/25 15:00:00 Marketing Sentinel
During the last session, Adicet Bio Inc. (NASDAQ:ACET)’s traded shares were 0.79 million, with the beta value of the company hitting 2.42. At the end of the trading day, the stock’s price was $13.63, reflecting an intraday gain of 13.39% or $1.61. The 52-week high for the ACET share is $21.17, that puts it down … Following Its 52-Week Low, Adicet Bio Inc. (NASDAQ: ACET)’S Share Price Rose 54.15% And Its YTD Numbers Fell -22.07% Read More »